Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise ...

Over the years, there has been a rise in preference for self-administration of drugs / therapies, resulting in an increasing demand for user-friendly drug ...

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, ...